Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

Inclusion Criteria: * Written consent to participate in the study * Male or female greater than or equal to 40 years of age * Body mass index (BMI) less than or equal to 40 kg/m2 * Ambulatory and in good general health * Willing and able to comply with the study procedures and visit schedules and able to follow verbal and written instructions * Willing to abstain from use of protocol-restricted treatments from Screening through End-of-Study visit * Symptoms consistent with OA of the index joint for ≥ 6 months prior to Screening (patient reported is acceptable) * Pain in the index joint for greater than15 days over the last month (as reported by the patient) * For Shoulder OA patients: Radiologic findings of OA of the index shoulder meeting the Samilson-Prieto (S-P) Classification Grades 2 or 3 * For Hip OA patients: ACR Criteria (clinical and radiological) for OA of the index hip Exclusion Criteria: * Reactive arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or arthritis associated with inflammatory bowel disease * History of infection in the index joint * Clinical findings consistent with active infection or crystal disease in the index joint within 1 month of Screening * History of fracture in the index limb within 12 months of Screening, or fracture with sequelae at any time * Planned or anticipated surgery of the index joint during the study period * Index joint instability or history of acute dislocation within 12 months of Screening * If …